CM Hospitalar S/A (BVMF:VVEO3)
Brazil · Delayed Price · Currency is BRL 1.440
+0.140 (10.77%)
At close: Oct 31, 2025
CM Hospitalar S/A Revenue
CM Hospitalar S/A had revenue of 2.82B BRL in the quarter ending June 30, 2025, with 2.49% growth. This brings the company's revenue in the last twelve months to 11.48B, up 0.30% year-over-year. In the year 2024, CM Hospitalar S/A had annual revenue of 11.58B with 4.51% growth.
Revenue (ttm)
11.48B
Revenue Growth
+0.30%
P/S Ratio
0.04
Revenue / Employee
1.91M
Employees
6,000
Market Cap
454.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.58B | 499.54M | 4.51% |
| Dec 31, 2023 | 11.08B | 2.34B | 26.72% |
| Dec 31, 2022 | 8.75B | 2.53B | 40.65% |
| Dec 31, 2021 | 6.22B | 1.81B | 40.91% |
| Dec 31, 2020 | 4.41B | 1.41B | 46.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 52.81B |
| Raia Drogasil | 40.96B |
| Diagnósticos da América | 13.93B |
| Empreendimentos Pague Menos | 13.68B |
| Fleury | 7.84B |
| Hypera | 6.97B |
| Oncoclínicas do Brasil Serviços Médicos | 6.16B |
| Dimed S.A. Distribuidora de Medicamentos | 5.16B |